← FDA Drug Approvals (Drugs@FDA)
FUROSEMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SABA ILAC SANAYIVE · Approved 2024-04-02
Drug application
- FDA Application #
ANDA215856- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FUROSEMIDE
- Generic name
- FUROSEMIDE
- Active ingredients
- FUROSEMIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- SABA ILAC SANAYIVE
- Manufacturer
- Devatis Inc.
- First approval
- 2024-04-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown